Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank description Gene Value Type Network Comparison Type Interaction Map Filtered green red network_comparison
Results: HTML CSV LaTeX Showing element 101 to 150 of 19268 in total 
Value Type: Measured

\def\wcA{0.11111111111111\textwidth}
\def\wcB{0.11111111111111\textwidth}
\def\wcC{0.11111111111111\textwidth}
\def\wcD{0.11111111111111\textwidth}
\def\wcE{0.11111111111111\textwidth}
\def\wcF{0.11111111111111\textwidth}
\def\wcG{0.11111111111111\textwidth}
\def\wcH{0.11111111111111\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
Filtered\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{4}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
13\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-b4 (hox-2f) (hox-2.6). [source:swissprot;acc:p17483]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
2108.6\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
jumonji domain containing 1; zinc finger protein; testis-specific protein a. [source:refseq;acc:nm\_018433]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
2959.19\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1927.68\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.5351\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vb (myosin 5b) (fragment). [source:swissprot;acc:q9ulv0]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
27904.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21591.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
6313\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
sorcin (22 kda protein) (cp-22) (v19). [source:swissprot;acc:p30626]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
3953.32\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2961.07\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
992.25\vspace{3pt}}\\\cline{1-2}\cline{4-4}\cline{6-8}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
14\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis inhibitor fksg2. [source:swissprot;acc:q9hau6]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
12125.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
10817.1\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1308\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin h (mo15-associated protein) (p37) (p34). [source:swissprot;acc:p51946]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
6.50325\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
130.512\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
20.0687\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit-like protein 1 (g protein beta-subunit like protein 1) (wd40 repeat containing protein deleted in vcfs) (wdvcf protein) (fksg1 protein) (dgcrk3). [source:swissprot;acc:q9byb4]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
59\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5900000\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c5 (hox-3d) (cp11). [source:swissprot;acc:q00444]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
2108.6\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vc (myosin 5c). [source:swissprot;acc:q9nqx4]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
27904.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21591.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
6313\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ras gtpase-activating protein ngap (ras protein activator like 1). [source:swissprot;acc:q9ujf2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
398.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
rho gdp-dissociation inhibitor 1 (rho gdi 1) (rho-gdi alpha). [source:swissprot;acc:p52565]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
16295.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
17235.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
940.4\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
trypsin iii precursor (ec 3.4.21.4) (brain trypsinogen) (mesotrypsinogen) (trypsin iv). [source:swissprot;acc:p35030]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
2998.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1972.65\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.51983\vspace{3pt}}\\\cline{1-3}\cline{6-8}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
15\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-c6 (hox-3c) (hho.c8) (cp25). [source:swissprot;acc:p09630]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
2108.6\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
lipopolysaccharide-responsive and beige-like anchor protein (cdc4-like protein) (beige-like protein). [source:swissprot;acc:p50851]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2740.13\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
485.286\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.64642\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
myosin va (myosin 5a) (dilute myosin heavy chain, non-muscle) (myosin heavy chain 12) (myoxin). [source:swissprot;acc:q9y4i1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
27904.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21591.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
6313\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
myotubularin related protein 8. [source:refseq;acc:nm\_017677]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
4823.8\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3888.6\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
935.2\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial precursor (cybs) (succinate-ubiquinone reductase membrane anchor subunit) (qps2) (cii-4) (succinate dehydrogenase complex subunit d) (succinate-ubiquinone oxidoreductase cytochrome b small subunit). [source:swissprot;acc:o14521]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
156\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
10\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
15.6\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
trypsin i precursor (ec 3.4.21.4) (cationic trypsinogen). [source:swissprot;acc:p07477]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3007.85\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1983.91\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.51612\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-like protein smt3b (sentrin 2) (hsmt3). [source:swissprot;acc:p55855]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
6685.11\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
7981.68\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1296.57\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
xpa binding protein 1; mbd2 interactor protein; putative atp(gtp)-binding protein. [source:refseq;acc:nm\_007266]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
871\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2671\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
3.06659\vspace{3pt}}\\\cline{1-2}\cline{4-4}\cline{6-8}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
16\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
28s ribosomal protein s17, mitochondrial precursor (mrp-s17) (hspc011). [source:swissprot;acc:q9y2r5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like 2 isoform a; autophagy-related cysteine endopeptidase 2; autophagin 2. [source:refseq;acc:nm\_052936]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
18172.1\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
24260.3\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
6088.2\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-d4 (hox-4b) (hox-5.1) (hho.c13). [source:swissprot;acc:p09016]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
2108.6\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
nif3-like protein 1 (amyotrophic lateral sclerosis 2 chromosomal region candidate gene protein 1) (my018 protein) (mds015). [source:swissprot;acc:q9gzt8]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
7572.88\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
8852.4\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1279.52\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase, lysine deficient 3. [source:refseq;acc:nm\_020922]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
704.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
125\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.636\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein transport protein sec24c (sec24-related protein c). [source:swissprot;acc:p53992]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
15\vspace{3pt}}\\\cline{2-2}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein x 0004. [source:refseq;acc:nm\_016301]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
871\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
2671\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
3.06659\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
vps10 domain-containing receptor sorcs1 precursor (hsorcs). [source:swissprot;acc:q8wy21]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
9808\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
8926.33\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
881.67\vspace{3pt}}\\\cline{1-2}\cline{4-4}\cline{6-8}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
17\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ba271b5.1 (similar to ribosomal protein s7). [source:sptrembl;acc:q9h1s9]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
12473\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
11223\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1250\vspace{3pt}}\\\cline{2-3}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
dgcr14 protein (digeorge syndrome critical region 14) (es2 protein). [source:swissprot;acc:q96df8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1365\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
460\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
2.96739\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ena/vasodilator stimulated phosphoprotein-like protein (ena/vasp-like protein). [source:swissprot;acc:q9ui08]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5837.83\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
4959.42\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
878.41\vspace{3pt}}\\\cline{2-2}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-b5 (hox-2a) (hho.c10) (hu-1). [source:swissprot;acc:p09067]\vspace{3pt}}&&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
2108.6\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3b (map1a/map1b lc3 b) (map1a/1b light chain 3 b). [source:swissprot;acc:q9gzq8]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
18168.9\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
24255.7\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
6086.8\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial solute carrier protein. [source:refseq;acc:nm\_145305]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
28492\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
21185\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.34491\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
mln 64 protein (star-related lipid transfer protein 3) (stard3) (start domain-containing protein 3) (cab1 protein). [source:swissprot;acc:q14849]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
859\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
14.8103\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
ptd016 protein. [source:refseq;acc:nm\_016125]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
158\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
30\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.26667\vspace{3pt}}\\\cline{1-2}\cline{4-4}\cline{6-8}
\multirow{8}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
18\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l37a. [source:swissprot;acc:p12751]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
26.1599\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
305.45\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
11.6763\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
anaphase promoting complex subunit 11 (hepatocellular carcinoma associated ring finger protein) (hspc214). [source:swissprot;acc:q9nyg5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
14167\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15411.3\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1244.3\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
camp-regulated phosphoprotein 19 (arpp-19) [contains: camp-regulated phosphoprotein 16 (arpp-16)]. [source:swissprot;acc:p56211]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
19\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
99\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
5.21053\vspace{3pt}}\\\cline{2-2}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
cyclic-amp-dependent transcription factor atf-3 (activating transcription factor 3). [source:swissprot;acc:p18847]\vspace{3pt}}&&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
7251\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
5492.04\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.32027\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hox-a5 (hox-1c). [source:swissprot;acc:p20719]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
17572.7\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
15464.1\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
2108.6\vspace{3pt}}\\\cline{2-2}\cline{4-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated proteins 1a/1b light chain 3a (map1a/map1b lc3 a) (map1a/1b light chain 3 a). [source:swissprot;acc:q9h492]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&&\parbox{\wcF}{\vspace{3pt}\noindent
18168.9\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
24255.7\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
6086.8\vspace{3pt}}\\\cline{2-2}\cline{4-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
mln 64 protein (star-related lipid transfer protein 3) (stard3) (start domain-containing protein 3) (cab1 protein). [source:swissprot;acc:q14849]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
58\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
859\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
801\vspace{3pt}}\\\cline{2-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
677.5\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}\\\cline{1-2}\cline{5-8}
\multirow{6}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial precursor (ec 1.14.-.-) (25-ohd-1 alpha-hydroxylase) (25-hydroxyvitamin d3 1- alpha-hydroxylase) (vd3 1a hydroxylase) (p450c1 alpha) (p450vd1- alpha). [source:swissprot;acc:o15528]\vspace{3pt}}}&&&\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
26.1599\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
305.45\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
11.6763\vspace{3pt}}\\\cline{4-8}
&&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
3915.4\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3032.56\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1.29112\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
cysteine endopeptidase aut-like isoform b. [source:refseq;acc:nm\_178326]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
18164.9\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
24250\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
6085.1\vspace{3pt}}\\\cline{2-2}\cline{5-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
dj570f3.6 (novel protein similar to lysophospholipase ii (lypla2)). [source:sptrembl;acc:q9uge0]\vspace{3pt}}&&&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
2804\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1593\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
1211\vspace{3pt}}\\\cline{2-4}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid desaturase 1; linoleoyl-coa desaturase (delta-6-desaturase)-like 1; delta-5 desaturase; delta-5 fatty acid desaturase. [source:refseq;acc:nm\_013402]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&&\parbox{\wcF}{\vspace{3pt}\noindent
662\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
153\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
4.3268\vspace{3pt}}\\\cline{2-3}\cline{6-8}
&\parbox{\wcB}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&&&\parbox{\wcF}{\vspace{3pt}\noindent
2407.27\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
3205.98\vspace{3pt}}&\parbox{\wcH}{\vspace{3pt}\noindent
798.71\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/